CB4211

Health & Fitness

CohBar Granted U.S. Patent Covering CB4211 Compositions and Use for Treating Nonalcoholic Steatohepatitis (NASH)

By Agnes E. Utt 5 years ago

MENLO PARK, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical